Sector portfolio · VC firm · United States

Redmile Group's Biotech portfolio

Redmile Group has backed 57 Biotech startups in rounds we track, $13B between them, shown by the stage each has reached. The best-funded is Blueprint Medicines.

57startups backed
4stages
$13Braised between them
Series C and laterbiggest stage

Redmile Group's whole portfolioRedmile Group's profile

Series C and later

19

Series B

17

Stage not reported

15

Series A

6

Segment by segment

Series C and later

19 startups · $5.5B raised

  1. Blueprint MedicinesBlueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.United States$1.4B
  2. Kymera TherapeuticsKymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.United States$799M
  3. ADC TherapeuticsADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.Switzerland$646M
  4. ElevateBioElevateBio is a biotechnology company based in Waltham, Massachusetts, founded in 2017.United States$551M
  5. AAtrecaAtreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.United States$313M
  6. Science 37Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.United States$236M
  7. IGM BiosciencesIGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.United States$209M
  8. Lycia TherapeuticsLycia Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California.United States$182M

Series B

17 startups · $3.5B raised

  1. BBioNTechGermany$687M
  2. Wave Life SciencesWave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling United States$434M
  3. Pliant TherapeuticsPliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.United States$350M
  4. Beam TherapeuticsBeam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.United States$322M
  5. Strand TherapeuticsStrand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.United States$267M
  6. Stoke TherapeuticsStoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.United States$255M
  7. Repare TherapeuticsRepare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.Canada$252M
  8. Annexon BiosciencesAnnexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.United States$180M

Stage not reported

15 startups · $2.3B raised

  1. Oruka TherapeuticsOruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.United States$880M
  2. Nurix TherapeuticsNurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.United States$250M
  3. Rapt TherapeuticsRapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.United States$250M
  4. Cabaletta BioCabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.United States$200M
  5. True North TherapeuticsTrue North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.United States$142M
  6. Replimune GroupReplimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.United States$140M
  7. InvivydInvivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.United States$125M
  8. Entrada TherapeuticsEntrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.United States$100M

Series A

6 startups · $1.2B raised

  1. Nuvation BioNuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.United States$675M
  2. NeurogeneNeurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.United States$194M
  3. Redx PharmaRedx Pharma is a drug discovery and development company.United Kingdom$127M
  4. Mnemo TherapeuticsMnemo Therapeutics is a biotechnology company based in Paris, founded in 2019.France$90M
  5. AAttenuaUnited States$35M
  6. LifeSproutLifeSprout offers revolutionary products for soft tissue replacement and regenerationUnited States$35M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Redmile Group as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Portfolio mapRedmile Group portfolio map75 startups · $14BCo-investorsWho invests with Redmile Group58 co-investorsSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426BSector portfolioGeneral Catalyst's AI portfolio226 startups · $179B

Raising from investors like Redmile Group?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps